Company Foresee Pharmaceuticals Co., Ltd.
Equities
6576
TW0006576002
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
94.3 TWD | +0.53% | -1.77% | -1.98% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
New Drug Development
100.0
%
| 302 | 100.0 % | 195 | 100.0 % | -35.31% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
100.0
%
| 302 | 100.0 % | 195 | 100.0 % | -35.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Hua Li
FOU | Founder | - | 09/15/09 |
Benjamin Chien
CEO | Chief Executive Officer | - | 08/13/08 |
Max Chan
DFI | Director of Finance/CFO | 56 | 07/19/07 |
Chief Tech/Sci/R&D Officer | - | 17/23/17 | |
Sheng Lee Yi
CTO | Chief Tech/Sci/R&D Officer | - | 10/13/10 |
Mathieu Boudreau
COO | Chief Operating Officer | - | - |
Wenjin Yang
CTO | Chief Tech/Sci/R&D Officer | - | 21/15/21 |
Bill Miller
LAW | General Counsel | - | 19/21/19 |
David Lau
PRN | Corporate Officer/Principal | - | - |
Jiarong Zhuang
AUD | Comptroller/Controller/Auditor | - | 13/18/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Lee
BRD | Director/Board Member | 73 | 03/15/03 |
Benjamin Chien
CEO | Chief Executive Officer | - | 08/13/08 |
Fu Shiow Yin
BRD | Director/Board Member | - | 31/16/31 |
Kun Hung Lai
BRD | Director/Board Member | - | 26/18/26 |
Wen Chi Lee
BRD | Director/Board Member | - | 31/16/31 |
Chia Lin Wang
BRD | Director/Board Member | - | 31/16/31 |
Chang Jen Yan
BRD | Director/Board Member | - | 10/13/10 |
Sheng Lee Yi
CTO | Chief Tech/Sci/R&D Officer | - | 10/13/10 |
Ben Liu
BRD | Director/Board Member | - | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 135,817,300 | 90,710,142 ( 66.79 %) | 0 | 66.79 % |
Company contact information
Foresee Pharmaceuticals Co., Ltd.
9F-2, No.19-3, Sanchong Road Nangang District
115, Taipei
+
http://www.foreseepharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.98% | 393M | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+1.17% | 41.76B | |
-4.27% | 28.8B | |
+11.42% | 26.05B | |
-21.39% | 19.15B | |
+4.86% | 12.55B | |
+27.29% | 12.34B | |
-3.50% | 11.82B |
- Stock Market
- Equities
- 6576 Stock
- Company Foresee Pharmaceuticals Co., Ltd.